CLINIMIX
BAXTER CORPORATION
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is CLINIMIX discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that CLINIMIX 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG 16.6G 365MG 280MG 290MG has been permanently discontinued (last updated December 8, 2022). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is CLINIMIX not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02142260
Strength
200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG 16.6G 365MG 280MG 290MG
Dosage Form
SOLUTION
Route
INTRAVENOUS
Active Ingredient
METHIONINE L-ISOLEUCINE L-VALINE HISTIDINE L-THREONINE TRYPTOPHAN L-ALANINE L-ARGININE L-PROLINE SERINE GLYCINE L-TYROSINE DEXTROSE L-LEUCINE L-PHENYLALANINE LYSINE
Compare with another product →
Shortage History
Other Products from BAXTER CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 00438014
DIN 00786292
DIN 00438049
DIN 00786209
DIN 00437999
DIN 00786217
DIN 00438030
DIN 00438022
DIN 00438006
DIN 00828602
900MG · DIN 00060208
900MG · DIN 00786160